Effects of antiplatelet therapy on platelet extracellular vesicle release and procoagulant activity in health and in cardiovascular disease

Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis

(2014) P. P. Wisman et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A simple flow cytometry method improves the detection of phosphatidylserine-exposing extracellular vesicles

(2014) N. Arraud et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing

(2014) E. van der Pol et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression

(2013) O. Gidlof et al.   BLOOD

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

(2013) Gregg W Stone et al.   LANCET

Microparticles: major transport vehicles for distinct microRNAs in circulation

(2012) P. Diehl et al.   CARDIOVASCULAR RESEARCH

Microparticles in cardiovascular disease pathophysiology and outcomes

(2012) Anthony J. Viera et al.   Journal of the American Society of Hypertension

High on Treatment Platelet Reactivity

(2011) Omar Ait-Mokhtar et al.   Heart Lung and Circulation

Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT

(2009) David E Connor et al.   BLOOD COAGULATION & FIBRINOLYSIS

The active metabolite of prasugrel effectively blocks the platelet P2Y12receptor and inhibits procoagulant and pro-inflammatory platelet responses

(2008) Heather M. Judge et al.   PLATELETS